Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
2
×
life sciences
national blog main
national top stories
alirocumab
alnylam pharmaceuticals
amgen
biopharma
boston
clinical trials
duchenne
europe blog main
europe top stories
evolocumab
fda
inclisiran
licensing
m&a
muscular dystrophy
new york
new york blog main
new york top stories
novartis
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
roche
sanofi
sarepta therapeutics
the medicines company
What
billion
2
×
deal
fda
2
×
acquire
agreed
approval
betting
biopharma
brings
cash
cholesterol
company
compound
drug
duchenne
gene
historic
medco
medicine
medicines
new
novartis
poised
puts
ready
recently
rna
roche
sarepta
second
swiss
therapeutics
therapy
wave
won
Language
unset
Current search:
deals
×
billion
×
fda
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
